Suzanne M Healy
Visit Investigator ProfileInvestigation Details
Detailed Analysis
Healy's approach is meticulous and thorough; she places particular emphasis on process compliance and detailed documentation. She underscores the importance of CAPA effectiveness verification, accurate risk analyses, and prompt and accurate incident reporting.
FDA inspector Suzanne M Healy appears to show a predilection for matters of design validation, risk analysis, and complaint handling. She displays an eye for detail, focusing especially on adequacy of processes and adherence to regulatory measures. She showcases a strong understanding of Corrective and Preventive Action (CAPA) procedures, device corrections and removal reporting, and Medical Device Reporting (MDR) requirements.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies